Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study

Find Full text
Thumbnail
Fulltext:
207862.pdf
Embargo:
until further notice
Size:
266.7Kb
Format:
PDF
Description:
publisher's version
Publication year
2019
Author(s)
Matulonis, U.A.
Shapira-Frommer, R.
Santin, A.D.
Lisyanskaya, A.S.
Pignata, S.
Vergote, I.
Ottevanger, P.B.
Ruman, J.
Ledermann, J.A.
Source
Annals of Oncology, 30, 7, (2019), pp. 1080-1087
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/207862   https://hdl.handle.net/2066/207862
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.